Recor Medical

Recor Medical, Inc. is a clinical-stage medical device company based in Palo Alto, California, specializing in the development of a therapeutic non-focused ultrasound system for renal denervation in patients with resistant hypertension. The company’s primary offering, the PARADISE technology, features a percutaneous renal denervation system that utilizes a six French catheter equipped with a cylindrical transducer. This system emits ultrasound energy circumferentially to facilitate an efficient renal denervation procedure. By combining high-intensity ultrasound energy with water-based cooling of the renal artery, the technology aims to reduce the over-activity of renal nerves, ultimately lowering blood pressure in patients. ReCor Medical's products are distributed through dealers in Scandinavia, Northern Europe, and Italy. Founded in 2009, the company operates as a subsidiary of Otsuka Holdings Co., Ltd. following a transaction announced in July 2018.